Alkermes, Teva settle patent suit around opioid-blocker Vivitrol, paving way for generics after three-year fight
Alkermes has agreed to give Teva a license to make a generic version of its opioid-blocking drug Vivitrol in order to stop patent litigation that …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
